Proven DCT strategies and technologies to boost study performance
By intelligently connecting decades of clinical trial expertise with proven technology-enabled DCT strategies and site support, IQVIA Decentralized Trials solutions deliver clinical services and technologies that engage the right patients, wherever they are. Helping sponsors expand geographic reach and access, while ensuring compliance and operational efficiencies throughout their trials.
As the biopharma industry strives to deliver more site-centric, patient focused clinical trials, integrating decentralized approaches starting from protocol design helps sponsors select and deploy innovative solutions that reduce patient burden and streamline operational execution to capture time and savings in every trial.
With over 500 DCTs underway across more than 75 countries and with patients across 30+ indications, IQVIA has the experience, capabilities and reach to meet any sponsor's needs.
Please fill out the form to speak to an IQVIA expert and learn more
New thinking about decentralized trials
Patient Centricity by Design
Improve patient engagement and retention while reducing burden with scalable, adaptable decentralized trials.
The Risks of Running Your Own DCT technology
With sponsors eager to scale remote research of clinical trials we explore the risks and rewards of building, purchasing, or licensing DCT technology.
Fierce Biotech Podcast – Episode 1 – Eric Klaver
IQVIA supports sites and participants through patient-centric trial experiences | Fierce Biotech
